Company Overview and News

 
Real Estate Investar Group achieves guidance milestone

2017-01-31 proactiveinvestors.com.au
Real Estate Investar Group (ASX:REV) grew its member base to 250,124 at the end of the December quarter meaning it achieved its initial public offer (IPO) forecast of 250,000 members.
Upvote Downvote

 
Real Estate Investar Ltd hits 240,000 members

2016-11-17 proactiveinvestors.com.au
Real Estate Investar Ltd (ASX:REV) is on track to hit its goal of 250,000 members by the end of 2016 after recently hitting the milestone of 240,000 members.
Upvote Downvote

 
Real Estate Investar Group Ltd grows revenue by 31% in FY16

2016-10-07 proactiveinvestors.com.au
Real Estate Investar Group Ltd (ASX:REV) has grown revenue by 31.7% to $5.29 million and surpassed 200,000 members for its online property investment tools business in FY16. Members are a key value driver, they are offered a free set of online tools to analyse investment properties - REI then monetises members through paid subscriptions and other products and services. Members grew to 48% over the year to 202,423 from 136,815.
Upvote Downvote

 
Real Estate Investar Group Ltd grows revenue by 31% in FY16

2016-09-30 proactiveinvestors.com.au
Real Estate Investar Group Ltd (ASX:REV) has grown revenue by 31.7% to $5.29 million and surpassed 200,000 members for its online property investment tools business in FY16. Members are a key value driver, they are offered a free set of online tools to analyse investment properties - REI then monetises members through paid subscriptions and other products and services. Members grew to 48% over the year to 202,423 from 136,815.
Upvote Downvote

 
Real Estate Investar Ltd's Clint Greaves talks monetisation strategy with investors

2016-08-05 proactiveinvestors.com.au
Real Estate Investar Group Ltd (ASX:REV) listed on the ASX in December 2015 and is a provider of online tools for property investors in Australia and New Zealand. Members are offered free access to online tools - REI then monetise this through a range of paid subscription and transaction up sell products and services. Members are a key driver of value and a performance indicator for the company who aims to have 250,000 members by December 2016.
Upvote Downvote

 
Proactive Spotlight CEO Investor Sessions: Cellmid, Anatara, Hazer, Zelda Therapeutics, Real Estate Investar

2016-07-25 proactiveinvestors.com.au
Proactive Investors is delighted to invite you to attend Proactive's Spotlight CEO Investor Session in Sydney on Wednesday 3rd August 2016. It promises to be another fascinating Investor Session. Registrations are already filling up, so you better be quick. REGISTER HERE: Wednesday, 3rd August
Upvote Downvote

 
Real Estate Investar Group Ltd fuels growth with acquisition and partnership

2016-07-25 proactiveinvestors.com.au
Real Estate Investar Group Ltd (ASX:REV), a provider of online property investment tools, is on track to reach prospectus milestones after a recent partnership and acquisition. REI entered a partnership with major shareholder, Domain, which has an audience of 6.9 million Australians. Furthermore, REI most recently acquired New Zealand property sales business, The Property Factory. Members are a key driver of value and a performance indicator for the company and these most recent moves by REI will help boost membership numbers.
Upvote Downvote

 
Real Estate Investar Group Ltd brings online services to CEO Spotlight Session

2016-07-22 proactiveinvestors.com.au
Real Estate Investar Group Ltd (ASX:REV) listed on the ASX in December 2015 and is a provider of online tools for property investors in Australia and New Zealand. Members are offered free access to online tools - REI then monetise this through a range of paid subscription and transaction up sell products and services. Members are a key driver of value and a performance indicator for the company who aims to have 250,000 members by December 2016.
Upvote Downvote

 
Proactive Spotlight CEO Investor Sessions: Cellmid, Anatara, Hazer, Zelda Therapeutics

2016-07-21 proactiveinvestors.com.au
Proactive Investors is delighted to invite you to attend Proactive's Spotlight CEO Investor Session in Sydney on Wednesday 3rd August 2016. It promises to be another fascinating Investor Session. Registrations are already filling up, so you better be quick. REGISTER HERE: Wednesday, 3rd August
Upvote Downvote

 
Real Estate Investar Group Ltd helps investors find a bargain property

2016-06-15 proactiveinvestors.com.au
Proactive Investors is a global leader in financial news, media, research and events focusing on emerging growth companies across four continents.
Upvote Downvote

 
 
Q3 Update

2016-04-29 asx.com.au
Upvote Downvote

Related Articles

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...

VSTM: Verastem Analysis and Research Report

2018-04-12 - Asif

Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...